446 related articles for article (PubMed ID: 34438351)
21. Clinical effect of progressive pulmonary fibrosis on patients with connective tissue disease-associated interstitial lung disease: a single center retrospective cohort study.
Lee JK; Ahn Y; Noh HN; Lee SM; Yoo B; Lee CK; Kim YG; Hong S; Ahn SM; Kim HC
Clin Exp Med; 2023 Dec; 23(8):4797-4807. PubMed ID: 37831431
[TBL] [Abstract][Full Text] [Related]
22. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
Ma H; Lu J; Song Y; Wang H; Yin S
BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
[TBL] [Abstract][Full Text] [Related]
23. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
24. Lung function trajectory in progressive fibrosing interstitial lung disease.
Oldham JM; Lee CT; Wu Z; Bowman WS; Pugashetti JV; Dao N; Tonkin J; Seede H; Echt G; Adegunsoye A; Chua F; Maher TM; Garcia CK; Strek ME; Newton CA; Molyneaux PL
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737223
[TBL] [Abstract][Full Text] [Related]
25. Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease.
Kim K; Lee J; Jo YS
Ther Adv Respir Dis; 2023; 17():17534666231212301. PubMed ID: 37991015
[TBL] [Abstract][Full Text] [Related]
26. CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis.
Shou AY; Salvatore MM
Clin Imaging; 2023 Feb; 94():42-49. PubMed ID: 36493681
[TBL] [Abstract][Full Text] [Related]
27. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
[TBL] [Abstract][Full Text] [Related]
28. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
[TBL] [Abstract][Full Text] [Related]
29. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.
Chan C; Ryerson CJ; Dunne JV; Wilcox PG
BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127
[TBL] [Abstract][Full Text] [Related]
30. Current perspective of progressive-fibrosing interstitial lung disease.
Kishaba T
Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
32. Screening value of lung ultrasound in connective tissue disease related interstitial lung disease.
Huang Y; Liu T; Huang S; Qiu L; Luo F; Yin G; Xie Q
Heart Lung; 2023; 57():110-116. PubMed ID: 36182861
[TBL] [Abstract][Full Text] [Related]
33. Real-life prevalence of progressive fibrosing interstitial lung diseases.
Gagliardi M; Berg DV; Heylen CE; Koenig S; Hoton D; Tamirou F; Pieters T; Ghaye B; Froidure A
Sci Rep; 2021 Dec; 11(1):23988. PubMed ID: 34907290
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients.
Hu Y; Wang LS; Wei YR; Du SS; Du YK; He X; Li N; Zhou Y; Li QH; Su YL; Zhang F; Shen L; Weng D; Brown KK; Li HP
Chest; 2016 Jan; 149(1):201-8. PubMed ID: 26447566
[TBL] [Abstract][Full Text] [Related]
35. Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study.
Migita K; Arai T; Jiuchi Y; Izumi Y; Iwanaga N; Kawahara C; Suematsu E; Miyamura T; Tsutani H; Kawabe Y; Matsumura R; Mori S; Ohshima S; Yoshizawa S; Suenaga Y; Ogushi F; Kawabata M; Furukawa H; Matsui T; Bito S; Tohma S
Medicine (Baltimore); 2014 Nov; 93(26):e175. PubMed ID: 25474431
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q
Front Immunol; 2024; 15():1404828. PubMed ID: 38745647
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
38. [Interstitial pneumonia with autoimmune features: monocentric prospective study].
Akulkina LA; Shchepalina AA; Moiseev AS; Brovko MY; Sholomova VI; Moiseev SV
Ter Arkh; 2023 Apr; 95(3):224-229. PubMed ID: 37167143
[TBL] [Abstract][Full Text] [Related]
39. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
40. [The clinical features and prognosis of interstitial lung disease patients with positive anti-neutrophil cytoplasmic antibody].
Gao C; Sun X; Huang J; Peng M; Sun XF; Zhang T; Shi JH
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):362-368. PubMed ID: 32294819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
